Tesla’s star is fading -- here’s why two AI powerhouses with stronger growth and better valuations deserve your attention ...

Eli Lilly's Alzheimer's drug, donanemab (Kisqali), just got a thumbs-up from the European Medicines Agency's (EMA) expert ...

The markets' record run was also aided by a wave of upbeat second-quarter earnings. Of the 152 companies in the S&P 500 that ...

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Group 1 Automotive ( GPI – Research Report ), Chipotle ( CMG – Research Report) and Tesla ( TSLA ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The electric vehicle revolution has created massive winners, but the next decade could see a dramatic reversal of fortunes.

Tesla (NASDAQ: TSLA) reported declining revenue, profits, and cash flow, but reiterated plans for a lower-priced model for this year. Where to invest $1,000 right now? Our analyst team just revealed ...

Tesla reported Q2 2025 revenue of $22.5-billion and adjusted EPS of $0.40, roughly in line with consensus but slightly below ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Chicago, IL – July 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity ...

One of the more glaring omissions from Tesla’s late Wednesday earnings was that the EV maker Tesla did not update its 2025 ...

Gary Black criticizes Tesla for disaster earnings call and affordable Model Y. Questions valuation compared to other tech ...